Health Products
Health Products
231 | Re: Temporary Measures for GMP Certificate Consideration of Modern Drug Manufacturing Facilities During the Coronavirus Disease 2019 (COVID-19) Outbreak |
232 | Drug Act, B.E.2510 (1967) and amendment 2001 |
233 | Herbal Product Act, B.E.2562 (2019) |
234 | RE: Prescribing the List of Category 5 Narcotics, B.E. 2563 (2020) |
235 | Hazardous Substances Act, B.E. 2535 (1992) |
236 | Ministerial regulation prescribing fees, reduction of and exemption from fees for activities in relation to herbal products, B.E. 2563 (2020) |
237 | Ministerial regulation on application for license and issuance of license to produce, import or sell herbal products, B.E. 2563 (2020) |
238 | Re: Import inspection checkpoints for herbal products |
239 | Ministerial regulation on herbal product formula registration, notification and listing, B.E. 2563 (2020) |
240 | Re: prohibited diseases for permission grantees and persons on duty in relation to herbal products, B.E. 2563 (2020) |